BioView and ANGLE have opened up "a major market opportunity" with breast cancer partnership. Watch the interview with Dr. Alan Schwebel, BioView's CEO.
…
We are pleased to announce the presentation of our latest research poster: "Development of a Scoring System to Classify HER2 Protein Expression in Circulating Tumor Cells through Immunofluorescence Following Isolation Using Parsortix® Instruments
…
ANGLE Announces Partnership With BioView to develop a liquid biopsy circulating tumor cell (CTC) HER2 assay for breast cancer
…
Capio Biosciences and BioView Ltd Announce Collaboration to Develop Integrated Workflow for Sample to Answer Assay of Circulating Tumor Cells
…
BioView and INL spin-off RUBYnanomed start collaboration to improve cancer diagnostics
…
BioView and INL spin-off RUBYnanomed start collaboration to improve cancer diagnostics
…
Innovative CTC FISH test for early diagnosis of lung cancer introduced by Sanmed Biotech
…
Angle plc and BioView Press Release
…
Abbott Molecular presents a lung cancer multiplex fast FISH assay using BioView image analysis system
…
Angle plc and BioView joint CTC presentation at the upcoming 2020 Tri-Con meeting